Showing results (3291-3300 of 8,887) with videos related to
Sort By:
Pageof 889
BJU International|March 6, 2010
Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factorWilliam Boucher, Duraisamy Kempuraj, Margaret Michaelian, et al.BJU International|March 6, 2010
The recovery of urinary continence after radical retropubic prostatectomy: a randomized trial comparing the effect of physiotherapist-guided pelvic floor muscle exercises with guidance by an instruction folder onlyYvette Dubbelman, Jan Groen, Mark Wildhagen, et al.BJU International|January 14, 2010
Effect of prostate size on pathological outcome and biochemical recurrence after radical prostatectomy for prostate cancer: is it correlated with serum testosterone level?Taekmin Kwon, In Gab Jeong, Dalsan You, et al.BJU International|January 14, 2010
Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillanceMiguel A Lopez-Costea, Lluís Fumadó, David Lorente, et al.BJU International|January 14, 2010
Should experienced open prostatic surgeons convert to robotic surgery? The real learning curve for one surgeon over 3 yearsNicolas Doumerc, Carlo Yuen, Richard Savdie, et al.BJU International|January 14, 2010
Bone mineral content and prostate cancer risk: data from the Baltimore Longitudinal Study of AgingStacy Loeb, H Ballentine Carter, Edward M Schaeffer, et al.BJU International|January 14, 2010
Survival of patients with bladder cancer from a UK hospital: a 10-year follow-up studyVincent J Low, Duolao Wang, Paul D AbelBJU International|February 6, 2010
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomyShahrokh F Shariat, Robert S Svatek, Derya Tilki, et al.BJU International|February 27, 2010
A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasiaNihad A M Tamimi, Ivan Mincik, Scott Haughie, et al.BJU International|November 17, 2005
Factors contributing to the racial differences in prostate cancer mortalityAshutosh Tewari, Wolfgang Horninger, Alexandre E Pelzer, et al.Pageof 889